VisuMax Femtosecond Laser

Femtosecond Laser System For Refractive Correction

FDA Premarket Approval P150040 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of the protocol for the post-approval study (pas) protocol.

DeviceVisuMax Femtosecond Laser
Classification NameFemtosecond Laser System For Refractive Correction
Generic NameFemtosecond Laser System For Refractive Correction
ApplicantCarl Zeiss Meditec, Inc.
Date Received2018-12-11
Decision Date2019-07-25
PMAP150040
SupplementS004
Product CodeOTL
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product No
Applicant Address Carl Zeiss Meditec, Inc. 5160 Hacienda Drive dublin, CA 94568

Supplemental Filings

Supplement NumberDateSupplement Type
P150040Original Filing
S011 2022-11-22 30-day Notice
S010 2022-05-23 30-day Notice
S009 2021-01-25 30-day Notice
S008 2020-11-19 Normal 180 Day Track
S007 2020-10-29 30-day Notice
S006 2020-09-08 30-day Notice
S005 2020-03-20 30-day Notice
S004 2018-12-11 Normal 180 Day Track No User Fee
S003 2018-03-23 Panel Track
S002 2018-02-28 Real-time Process
S001 2017-01-06 Real-time Process

NIH GUDID Devices

Device IDPMASupp
04049471100136 P150040 012
04049471100167 P150040 012
04049471100150 P150040 012
04049471100143 P150040 012

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.